Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diagnosis and Treatment of Acute Myocardial Ischemia in Patients With Covid-19 Infection Publisher



Shemirani H1 ; Jafari R2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Hemodialysis, Noor and Hazrat-e-Ali Asghar Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2021


Abstract

Acute myocardial ischemia during coronavirus disease 2019 (COVID-19) infection can occur in two forms of acute myocardial infarction type І and II. In acute myocardial infarction type І, infection can cause inflammation, and inflammation causes the secretion and increase of cytokines such as interleukin 1, 6, and 8, as well as tumor necrosis factor (TNF) in the circulation. This mechanism causes the secretion of collagenase from activated macrophages, and the results of these reactions is a precursor to plaque rupture, increased coagulation, and thrombus formation. This mechanism causes acute myocardial infarction type І on atherosclerotic plaque. In these patients, primary percutaneous coronary intervention (PCI) is the treatment of choice, contrary to the initial theory that lytic therapy was the main treatment. In COVID conditions, the primary PCI time increases from 120 minutes to 180 minutes, and if the primary PCI takes more than 180 minutes, then lytic therapy is recommended. In acute myocardial infarction type II, patients usually do not have angina clinically, troponin rises slightly (less than 2 times normal), and do not have electrocardiogram changes as a sign of ischemia. However, patients with coronary heart disease have persistent chest pain with or without myocardial necrosis. During COVID-19 infection, due to release of interleukin, tumor necrosis alpha, and catecholamine, as well as hypoxia, acidosis, hypertension and/or hypotension, oxygen delivery and myocardial oxygen demand become disturbed, so acute myocardial infarction type II may occur. Supportive therapies are performed in these patients, and the treatment of acute underlying disease such as treatment with steroidal anti-inflammatory drugs and antiviral drugs is the main treatment. © 2021 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. A Review of Coronary Artery Thrombosis: A New Challenging Finding in Covid-19 Patients and St-Elevation Myocardial Infarction, Current Problems in Cardiology (2021)
2. Acute Cardiac Injury in Covid-19: A Systematic Review and Meta-Analysis, Archives of Iranian Medicine (2020)
3. A Mini-Review on Cardiovascular and Hematological Complications of Covid-19, Coronaviruses (2021)
4. A Review of Pathophysiological Mechanism, Diagnosis, and Treatment of Thrombosis Risk Associated With Covid-19 Infection, IJC Heart and Vasculature (2022)
5. Presentation and Outcome of Congenital Heart Disease During Covid-19 Pandemic: A Review, Current Problems in Cardiology (2022)
6. Epidemiology, Virology, Clinical Features, Diagnosis, and Treatment of Sars-Cov-2 Infection, Journal of Experimental and Clinical Medicine (Turkey) (2021)
7. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
8. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
Experts (# of related papers)
View all Related Experts
Ramin Sami (11)
Marjan Mansourian (9)
Other Related Docs
9. The Clinical Manifestation and Outcome of Covid-19 in Patients With a History of Ischemic Heart Disease; a Retrospective Case-Control Study, BMC Cardiovascular Disorders (2023)
10. Comprehensive Overview of Covid-19-Related Respiratory Failure: Focus on Cellular Interactions, Cellular and Molecular Biology Letters (2022)
11. Cardiac Involvement According to Echocardiographic Findings in Severe Coronavirus Disease 2019, ARYA Atherosclerosis (2021)
12. Gastrointestinal and Kidney Manifestations in Sarscov and Sars-Cov-2 Infections: Role of Angiotensin-Converting Enzyme 2, Physiology and Pharmacology (Iran) (2021)
13. Adrenal Insufficiency in Coronavirus Disease 2019 (Covid-19)-Infected Patients Without Preexisting Adrenal Diseases: A Systematic Literature Review, International Journal of Endocrinology (2021)
14. D-Dimer Levels in Predicting Severity of Infection and Outcome in Patients With Covid-19, Tanaffos (2022)
15. Severity of Disease and Covid-19 Complications During Hospital Stay: A Prospective Cohort Study, Archives of Iranian Medicine (2022)
16. Cardiovascular Complications of Covid-19 Among Pregnant Women and Their Fetuses: A Systematic Review, Journal of Clinical Medicine (2022)
17. The Correlation Between Viral Shedding Duration and Blood Biomarkers in Covid-19-Infected Patients, Journal of Research in Medical Sciences (2022)
18. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
19. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
20. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
21. Pulmonary Function, Anxiety, Depression, and Sleep Quality After Recovery From Covid-19, Tanaffos (2023)
22. Corona Virus Disease 2019 (Covid-19) and Its Effect on Renal System, a Systematic Review and Meta-Analysis, Iranian Journal of Kidney Diseases (2020)
23. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
24. Cardiovascular Risk Factors and Clinical Outcomes Among Patients Hospitalized With Covid-19: Findings From the World Heart Federation Covid-19 Study, Global Heart (2022)
25. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
26. Diagnostic and Prognostic Value of Sepsis-Induced Coagulopathy and International Society on Thrombosis and Hemostasis Scoring Systems in Covid-19-Associated Disseminated Intravascular Coagulopathy, Journal of Research in Medical Sciences (2021)
27. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
28. Gastrointestinal and Renal Complications in Sars-Cov-2-Infected Patients: Role of Immune System, Scandinavian Journal of Immunology (2021)
29. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
30. Arrhythmia in a Covid-19 Patient: A Case Report, Journal of Nephropharmacology (2023)
31. Demographic, Clinical, and Para Clinical Features in Patients With Covid-19 and St-Elevation Myocardial Infarction; [ویژگیهای دموگرافیک، کلینیکی و پاراکلینیکی در بیماران مبتال به انفارکتوس میوکارد با صعود قطعهی St و بیماری کووید- 91], Journal of Isfahan Medical School (2023)
32. A One-Year Hospital-Based Prospective Covid- 19 Open-Cohort in the Eastern Mediterranean Region: The Khorshid Covid Cohort (Kcc) Study, PLoS ONE (2020)
33. Model Prediction for In-Hospital Mortality in Patients With Covid-19: A Case–Control Study in Isfahan, Iran, American Journal of Tropical Medicine and Hygiene (2021)
34. N-Acetylcysteine and Coronavirus Disease 2019: May It Work As a Beneficial Preventive and Adjuvant Therapy? a Comprehensive Review Study, Journal of Research in Medical Sciences (2020)
35. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
36. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
37. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
38. Association of Clinical Features With Spike Glycoprotein Mutations in Iranian Covid-19 Patients, Journal of Clinical Medicine (2022)
39. Melting Curve-Based Assay As an Alternative Technique for the Accurate Detection of Sars-Cov-2, Advanced Biomedical Research (2022)
40. Multivariable Analysis of Clinical and Laboratory Data Manifestations Predicting Severity and Mortality Risk in Patients With Coronavirus Disease 2019 in the Mountainous West of Iran: A Retrospective Single-Center Study, Asian Biomedicine (2022)
41. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
42. Nanobased Platforms for Diagnosis and Treatment of Covid-19: From Benchtop to Bedside, ACS Biomaterials Science and Engineering (2021)
43. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
44. Factors Related to Preventive Covid-19 Behaviors Using Health Belief Model Among General Population: A Cross-Sectional Study in Iran, BMC Public Health (2021)
45. A Review on the Diagnostic Approaches of Covid-19 Infection; Features and Limitations, Journal of Isfahan Medical School (2021)
46. Skin Manifestations As Potential Symptoms of Diffuse Vascular Injury in Critical Covid-19 Patients, Journal of Cutaneous Pathology (2021)
47. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
48. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
49. Use of Complementary and Alternative Medicine in General Population During Covid-19 Outbreak: A Survey in Iran, Journal of Integrative Medicine (2022)
50. Prediction of Short-Term Clinical Outcome of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Through Myeloperoxidase Levels, ARYA Atherosclerosis (2014)